July 30th, 2011 by GarySchwitzer in Opinion
Tags: Accurate Health Care Information, ACSM, American College of Sports Medicine, Balanced Health Care Information, Evidence-Based Reporting, Health Care Interventions, Health Journalism, Health News Review, Health Reporting, Research Results, Smarter Health Care Decisions, Technology
No Comments »
For several years, I’ve been gently nudging various groups that communicate with the public about health care to adopt/endorse/promote the 10 criteria we use on HealthNewsReview.org in the same spirit in which we promote them: 10 things we think consumers need addressed in messages about health care interventions.
• What’s the total cost?
• How often do benefits occur?
• How often do harms occur?
• How strong is the evidence?
• Is this condition exaggerated?
• Are there alternative options?
• Is this really a new approach?
• Is it available to me?
• Who’s promoting this?
• Do they have a conflict of interest?
It may not be a perfect or complete list, but it’s not a bad starting point, and we now have data on more than 1,500 stories showing how these are – or are not – addressed in some of the public discussion.
I’ve urged the American Association of Medical Colleges, America’s Health Insurance Plans, news organizations, and news-release-writers, among others, to publish our criteria attached to their news releases or on their websites.
Many have been called. Many have nodded in agreement. None have responded.
Until now. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
July 30th, 2011 by Michael Kirsch, M.D. in Health Policy, Opinion
Tags: Approved Drugs, Drug Companies, Drug Reps, Drugs, Gastroenterology, Heartburn, Medications, Nexium, PBM, Pharmacy, Pharmacy Benefit Manager, Preferred Medicine, Prescription Drugs
No Comments »
As a gastroenterologist, I treat hundreds of patients with heartburn. You already know the names of the medicines I prescribe, since they are advertised day and night on television and appear regularly in print newspapers. Pharmaceutical representatives for each one of these drugs come to our office each claiming some unique clinical advantage of their products over the competitors. They have a tough job since the medicines are all excellent, are priced similarly and are safe. On some days we will have 2 or 3 reps visiting us, each one proffering a medical study or two that supports their product. They show us graphs where their drug is superior to the others regarding an event of questionable clinical import. Their goal is to show that the graph line of their drug is going up, while those of their competitors are going down.
Physicians, like me, who do give these folks some time, have mastered the art of the slow head nod as the drug’s virtues are being related. In the past, the relationships they cultivated with us translated directly into prescriptions being written. Not so today, when our prescribing pens are controlled by insurance company formulary requirements. Those drugs that are not on the coveted list not just swimming upstream, they’re trying to scale a waterfall.
Drug companies know a lot more about us than we know about them. They have Read more »
*This blog post was originally published at MD Whistleblower*
July 29th, 2011 by Davis Liu, M.D. in Opinion
Tags: Day Traders, Demanding Treatment, Diagnosis, Doctor-Patient Communication, Empowered Patient Movement, Kaiser Permanente, Mayo Clinic, Online Research of Symptoms, Patient Empowerment, Patient Engagment, Primary Care
3 Comments »
Let me say first that I am a practicing primary care doctor who is very much focused on patient centered care. Though I cannot go back to being a patient who is unaware about what a doctor does, the terminology she uses, or what the importance of certain test results are, I can empathize with the overwhelming amounts of information, challenges, and stressors patients and families can have in navigating the healthcare system to get the right care. This is the reason I wrote my book.
However, over the past few months I’ve noticed a particularly disturbing trend. Patients are not consulting doctors for advice, but rather demanding testing for diagnoses which are not even remote possibilities. A little knowledge can be dangerous particularly in the context of little to no clinical experience. Where many patients are today are where medical students are at the end of their second year – lots of book knowledge but little to no real world experience.
More patients are becoming the day traders of the dot.com boom. Everyone has Read more »
*This blog post was originally published at Saving Money and Surviving the Healthcare Crisis*
July 29th, 2011 by MuinKhouryMDPhD in Opinion, Research
Tags: Abacavir, Adverse Drug Effects, CDC, Center for Disease Control and Prevention, Department of Health and Human Services, FDA, Food and Drug Administration, Genetics, Genomics, HIV Treatment, HIV/AIDS, Pharmacogenomics, Public Health, Warfarin Dosing
1 Comment »
Adverse drug events are a serious public health problem. Consider the following facts:
- an estimated 82% of American adults take at least one medication and 29% take five or more;
- 700,000 emergency department visits and 120,000 hospitalizations are due to adverse drug events annually;
- $3.5 billion is spent on extra medical costs of adverse drug events annually;
- at least 40% of costs associated with adverse drug events occurring outside hospitals can be prevented.
How can genomics help? Pharmacogenomics is the study of genetic variation as a factor in drug response, affecting both safety and effectiveness. The intended applications of pharmacogenomics research include identifying responders and non-responders to medications, avoiding adverse events, optimizing drug dose and avoiding unnecessary healthcare costs. The Food and Drug Administration has added pharmacogenomic information to the labeling for more than 70 drugs. Labels may include information on genetic determinants of clinical response or risk for adverse events.
In spite of current enthusiasm about pharmacogenomics in the research community, Read more »
*This blog post was originally published at Genomics and Health Impact Blog*
July 28th, 2011 by John Mandrola, M.D. in Opinion
Tags: Cardiac Electrophysiologist, Cardiologist, Dr. Robert Centor, General Medicine, Good Patient Care, Hospitalists, Internist, Real Doctor, Sub-specialist, Unappreciated
No Comments »
Today I would like to say thanks to a group of colleagues that too often go un-thanked.
These would be my hospital-based internal medicine friends: hospitalists are what they are called.
This idea came to me after reading Dr Robert Centor’s post on KevinMD. In his usual concise manner, he laments the lack of respect that many sub-specialists show hospitalists.
I feel differently about my hard-working colleagues.
As a sub, sub-specialist who works primarily in the hospital, I would like to say how grateful I am to have knowledgeable, hospital-based internists available.
I believe, and write frequently about the importance of seeing the forest through the trees. A good doctor must see the big picture: a little atrial fib, for instance, isn’t a major problem if you can’t move, eat or have widespread Cancer.
But for good patient care, the details are important too. Hospitalists are good at details. In fact, Read more »
*This blog post was originally published at Dr John M*
